Physician profile
Jonathan Lerma
NPI 1013473677
$9,705.72
in general payments reported to CMS, 2019-2025
11 companies · $1,361 in 2025
The $1,361 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,607 · 2022: $1,580 · 2023: $1,160 · 2024: $3,997 · 2025: $1,361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,053 · Travel and Lodging: $1,407 · Education: $59.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,052.64 |
| Travel and Lodging | $1,406.52 |
| Education | $59.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $3,404.76 | 2023-2025 | Inspire |
| Medtronic, INC. | $3,398.77 | 2021-2025 | Propel, Fusion, Nuvent |
| Optinose US, INC. | $1,336.32 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $712.42 | 2021-2025 | Dupixent |
| Stryker Corporation | $469.58 | 2021-2024 | Scopis Ent, Xpress Ent Dilation System |
| Phadia US INC. | $197.68 | 2022-2025 | Immunocap |
| Olympus America INC. | $83.34 | 2023-2025 | Olympus, Rhino-Laryngo Videoscope |
| Acclarent, INC | $44.72 | 2023 | Trudi Nav Cable |
| Ars Pharmaceuticals Operations, INC. | $25.11 | 2025 | Neffy |
| Paratek Pharmaceuticals, INC. | $19.98 | 2025 | Xhance |
| Smith+Nephew, INC. | $13.04 | 2023 | Halo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Lerma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.